Platelet function determined by flow cytometry: New perspectives?

Seminars in Thrombosis and Hemostasis

Volumn 42, Issue 3, 2016, Pages 268-281

  Ramström, Sofia ^a   Södergren, Anna L ^a   Tynngård, Nahreen ^a   Lindahl, Tomas L ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

blood platelets; flow cytometry; platelet activation; platelet function testing

Indexed keywords

BLOOD CLOTTING FACTOR; CD63 ANTIGEN; COLLAGEN RECEPTOR; FIBRINOGEN RECEPTOR; GLYCOPROTEIN; LIPOCORTIN 5; PADGEM PROTEIN; THROMBOXANE A2;

ARTICLE; BLEEDING DISORDER; BLOOD CLOTTING PARAMETERS; DRUG SCREENING; EXOCYTOSIS; FLOW CYTOMETRY; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE; THROMBOSIS; TRANSFUSION MEDICINE; BLOOD PLATELET DISORDERS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; THROMBOCYTE; THROMBOCYTE AGGREGATION;

BLOOD PLATELET DISORDERS; BLOOD PLATELETS; FLOW CYTOMETRY; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THROMBOSIS;

EID: 84958780744     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0035-1570082     Document Type: Article

References (180)

1. Quiroga T., Mezzano D. Is my patient a bleeder? A diagnostic framework for mild bleeding disorders. Hematology Am Soc Hematol Educ Program: 2012; 2012 466 474
2. Hayward C. P., Moffat K. A., Pai M., et al. An evaluation of methods for determining reference intervals for light transmission platelet aggregation tests on samples with normal or reduced platelet counts. Thromb Haemost: 2008; 100 1 134 145
3. Shattil S. J., Cunningham M., Hoxie J. A. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood: 1987; 70 1 307 315
4. Merolla M., Nardi M. A., Berger J. S. Centrifugation speed affects light transmission aggregometry. Int J Lab Hematol: 2012; 34 1 81 85
5. Femia E. A., Pugliano M., Podda G., Cattaneo M. Comparison of different procedures to prepare platelet-rich plasma for studies of platelet aggregation by light transmission aggregometry. Platelets: 2012; 23 1 7 10
6. Lyon M. E., Fine J. S., Henderson P. J., Lyon A. W. D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone (PPACK): alternative anticoagulant to heparin salts for blood gas and electrolyte specimens. Clin Chem: 1995; 41 7 1038 1041
7. Ginsberg M. H., Lightsey A., Kunicki T. J., Kaufmann A., Marguerie G., Plow E. F. Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia. J Clin Invest: 1986; 78 4 1103 1111
8. Lindahl T. L., Festin R., Larsson A. Studies of fibrinogen binding to platelets by flow cytometry: an improved method for studies of platelet activation. Thromb Haemost: 1992; 68 2 221 225
9. Storey R. F., May J. A., Wilcox R. G., Heptinstall S. A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: comparison with other aggregation methodologies. Thromb Haemost: 1999; 82 4 1307 1311
10. Storey R. F., Wilcox R. G., Heptinstall S. Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists. Circulation: 1998; 98 16 1616 1621
11. 2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents. Thromb Haemost: 1989; 62 3 968 976
12. Packham M. A., Kinlough-Rathbone R. L., Mustard J. F. Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionized calcium. Blood: 1987; 70 3 647 651
13. Wallén N. H., Ladjevardi M., Albert J., Bröijersén A. Influence of different anticoagulants on platelet aggregation in whole blood; a comparison between citrate, low molecular mass heparin and hirudin. Thromb Res: 1997; 87 1 151 157
14. Laudano A. P., Cottrell B. A., Doolittle R. F. Synthetic peptides modeled on fibrin polymerization sites. Ann N Y Acad Sci: 1983; 408 315 329
15. Kawasaki K., Hirase K., Miyano M., Tsuji T., Iwamoto M. Amino acids and peptides. XVI. Synthesis of N-terminal tetrapeptide analogs of fibrin α-chain and their inhibitory effects on fibrinogen/thrombin clotting. Chem Pharm Bull (Tokyo): 1992; 40 12 3253 3260
16. Laudano A. P., Doolittle R. F. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. Biochemistry: 1980; 19 5 1013 1019
17. Michelson A. D. Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: methods and clinical applications. Blood Coagul Fibrinolysis: 1994; 5 1 121 131
18. Burgess J. K., Chong B. H. The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls. Eur J Haematol: 1997; 58 4 279 285
19. Messmore H. L. Jr, Griffin B., Fareed J., Coyne E., Seghatchian J. In vitro studies of the interaction of heparin, low molecular weight heparin and heparinoids with platelets. Ann N Y Acad Sci: 1989; 556 217 232
20. Kozek-Langenecker S. A., Mohammad S. F., Masaki T., Kamerath C., Cheung A. K. The effects of heparin, protamine, and heparinase 1 on platelets in vitro using whole blood flow cytometry. Anesth Analg: 2000; 90 4 808 812
21. Michelson A. D. Flow cytometry: a clinical test of platelet function. Blood: 1996; 87 12 4925 4936
22. Harrison P., Mackie I., Mumford A., et al. British Committee for Standards in Haematology. Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol: 2011; 155 1 30 44
23. Wallin O., Söderberg J., Grankvist K., Jonsson P. A., Hultdin J. Preanalytical effects of pneumatic tube transport on routine haematology, coagulation parameters, platelet function and global coagulation. Clin Chem Lab Med: 2008; 46 10 1443 1449
24. Glas M., Mauer D., Kassas H., Volk T., Kreuer S. Sample transport by pneumatic tube system alters results of multiple electrode aggregometry but not rotational thromboelastometry. Platelets: 2013; 24 6 454 461
25. Kaiser A. F., Neubauer H., Franken C. C., Krüger J. C., Mügge A., Meves S. H. Which is the best anticoagulant for whole blood aggregometry platelet function testing? Comparison of six anticoagulants and diverse storage conditions. Platelets: 2012; 23 5 359 367
26. Rubak P., Nissen P. H., Kristensen S. D., Hvas A. M. Investigation of platelet function and platelet disorders using flow cytometry. Platelets: 2016; 27 1 66 74
27. Ramström S., Oberg K. V., Akerström F., Enström C., Lindahl T. L. Platelet PAR1 receptor density-correlation to platelet activation response and changes in exposure after platelet activation. Thromb Res: 2008; 121 5 681 688
28. Schmitz G., Rothe G., Ruf A., et al. European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost: 1998; 79 5 885 896
29. Shattil S. J., Hoxie J. A., Cunningham M., Brass L. F. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem: 1985; 260 20 11107 11114
30. Goodall A. H., de Oliveira Domingos M., Chronos N., Janes S. L., Wilson D. J. Flow cytometric detection of the redistribution of the glycoprotein Ib-IX complex on thrombin-stimulated platelets is dependent on the type of antibody conjugate used. Blood: 1993; 81 5 1407 1409
31. Hulspas R., O'Gorman M. R., Wood B. L., Gratama J. W., Sutherland D. R. Considerations for the control of background fluorescence in clinical flow cytometry. Cytometry B Clin Cytom: 2009; 76 6 355 364
32. Maecker H. T., Trotter J. Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A: 2006; 69 9 1037 1042
33. Giebish G., Windhager E. Transport of urea, glucose, phosphate, calcium, magnesium and organic solutes. In: Boron W. F., Boulpaep E. L. eds. Medical Physiology. 2nd ed. Philadelphia, PA Saunders Elsevier: 2009; 797 820, Chapter 36
34. Rink T. J., Sage S. O. Calcium signaling in human platelets. Annu Rev Physiol: 1990; 52 431 449
35. Heemskerk J. W., Feijge M. A., Andree H. A., Sage S. O. Function of intracellular [Ca2+]i in exocytosis and transbilayer movement in human platelets surface-labeled with the fluorescent probe 1-(4-trimethylammonio)phenyl)-6-phenyl-1,3,5-hexatriene. Biochim Biophys Acta: 1993; 1147 2 194 204
36. Pasquet J. M., Dachary-Prigent J., Nurden A. T. Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur J Biochem: 1996; 239 3 647 654
37. Munnix I. C., Kuijpers M. J., Auger J., et al. Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation. Arterioscler Thromb Vasc Biol: 2007; 27 11 2484 2490
38. Feinman R. D., Detwiler T. C. Platelet secretion induced by divalent cation ionophores. Nature: 1974; 249 453 172 173
39. Thiagarajan P., Tait J. F. Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem: 1990; 265 29 17420 17423
40. Reutelingsperger C. P., Kop J. M., Hornstra G., Hemker H. C. Purification and characterization of a novel protein from bovine aorta that inhibits coagulation. Inhibition of the phospholipid-dependent factor-Xa-catalyzed prothrombin activation, through a high-affinity binding of the anticoagulant to the phospholipids. Eur J Biochem: 1988; 173 1 171 178
41. Andree H. A., Reutelingsperger C. P., Hauptmann R., Hemker H. C., Hermens W. T., Willems G. M. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem: 1990; 265 9 4923 4928
42. Mann K. G., Nesheim M. E., Church W. R., Haley P., Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood: 1990; 76 1 1 16
43. Berny-Lang M. A., Frelinger A. L. III, Barnard M. R., Michelson A. D. Flow cytometry. In: Michelson A. D. ed. Platelets. 3rd ed. San Diego, CA Academic Press: 2013; 581 602
44. Harrison P., Ault K. A., Chapman S., et al. International Society of Laboratory Hematology Task Force for the Reference Platelet Count. An interlaboratory study of a candidate reference method for platelet counting. Am J Clin Pathol: 2001; 115 3 448 459
45. Niccolai E., Emmi G., Squatrito D., et al. Microparticles: bridging the gap between autoimmunity and thrombosis. Semin Thromb Hemost: 2015; 41 4 413 422
46. Nomura S., Shimizu M. Clinical significance of procoagulant microparticles. J Intensive Care: 2015; 3 1 2
47. van der Pol E., Coumans F., Varga Z., Krumrey M., Nieuwland R. Innovation in detection of microparticles and exosomes. J Thromb Haemost: 2013; 11 01 36 45
48. Crompot E., Van Damme M., Duvillier H., et al. Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: the importance of an appropriate negative control. PLoS ONE: 2015; 10 5 e0127209
49. Freyssinet J. M., Toti F. Membrane microparticle determination: at least seeing what's being sized! J Thromb Haemost: 2010; 8 2 311 314
50. Harrison P., Gardiner C. Invisible vesicles swarm within the iceberg. J Thromb Haemost: 2012; 10 5 916 918
51. van der Pol E., van Gemert M. J., Sturk A., Nieuwland R., van Leeuwen T. G. Single vs. swarm detection of microparticles and exosomes by flow cytometry. J Thromb Haemost: 2012; 10 5 919 930
52. Bode A. P., Hickerson D. H. Characterization and quantitation by flow cytometry of membranous microparticles formed during activation of platelet suspensions with ionophore or thrombin. Platelets: 2000; 11 5 259 271
53. Lacroix R., Robert S., Poncelet P., Dignat-George F. Overcoming limitations of microparticle measurement by flow cytometry. Semin Thromb Hemost: 2010; 36 8 807 818
54. Södergren A. L., Tynngård N., Berlin G., Ramström S. Responsiveness of platelets during storage studied with flow cytometry - formation of platelet subpopulations and LAMP-1 as new markers for the platelet storage lesion (e-pub ahead of print). Vox Sang: 2015;; doi: 10.1111/vox.12324
55. Poncelet P., Robert S., Bouriche T., Bez J., Lacroix R., Dignat-George F. Standardized counting of circulating platelet microparticles using currently available flow cytometers and scatter-based triggering: Forward or side scatter? (e-pub ahead of print). Cytometry A: 2015;;doi: 10.1002/cyto.a.22685
56. Gresele P.; Subcommittee on Platelet Physiology. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost: 2015; 13 2 314 322
57. Michelson A. D., Benoit S. E., Kroll M. H., et al. The activation-induced decrease in the platelet surface expression of the glycoprotein Ib-IX complex is reversible. Blood: 1994; 83 12 3562 3573
58. Ginsberg M. H., Frelinger A. L., Lam S. C., et al. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies. Blood: 1990; 76 10 2017 2023
59. Frelinger A. L. III, Cohen I., Plow E. F., et al. Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. J Biol Chem: 1990; 265 11 6346 6352
60. Frelinger A. L. III, Lam S. C., Plow E. F., Smith M. A., Loftus J. C., Ginsberg M. H. Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. J Biol Chem: 1988; 263 25 12397 12402
61. Abrams C. S., Ellison N., Budzynski A. Z., Shattil S. J. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood: 1990; 75 1 128 138
62. Gralnick H. R., Williams S. B., McKeown L., et al. Endogenous platelet fibrinogen: its modulation after surface expression is related to size-selective access to and conformational changes in the bound fibrinogen. Br J Haematol: 1992; 80 3 347 357
63. Zamarron C., Ginsberg M. H., Plow E. F. Monoclonal antibodies specific for a conformationally altered state of fibrinogen. Thromb Haemost: 1990; 64 1 41 46
64. Faraday N., Goldschmidt-Clermont P., Dise K., Bray P. F. Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry. J Lab Clin Med: 1994; 123 5 728 740
65. Heilmann E., Hynes L. A., Burstein S. A., George J. N., Dale G. L. Fluorescein derivatization of fibrinogen for flow cytometric analysis of fibrinogen binding to platelets. Cytometry: 1994; 17 4 287 293
66. Schoolmeester A., Vanhoorelbeke K., Katsutani S., et al. Monoclonal antibody IAC-1 is specific for activated alpha2beta1 and binds to amino acids 199 to 201 of the integrin alpha2 I-domain. Blood: 2004; 104 2 390 396
67. Carmody M. W., Ault K. A., Mitchell J. G., Rote N. S., Ng A. K. Production of monoclonal antibodies specific for platelet activation antigens and their use in evaluating platelet function. Hybridoma: 1990; 9 6 631 641
68. Larsen E., Celi A., Gilbert G. E., et al. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell: 1989; 59 2 305 312
69. Stenberg P. E., McEver R. P., Shuman M. A., Jacques Y. V., Bainton D. F. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol: 1985; 101 3 880 886
70. Henn V., Slupsky J. R., Gräfe M., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature: 1998; 391 6667 591 594
71. Aiken M. L., Ginsberg M. H., Plow E. F. Mechanisms for expression of thrombospondin on the platelet cell surface. Semin Thromb Hemost: 1987; 13 3 307 316
72. Boukerche H., McGregor J. L. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets. Eur J Biochem: 1988; 171 1-2 383 392
73. Damas C., Vink T., Nieuwenhuis H. K., Sixma J. J. The 33-kDa platelet alpha-granule membrane protein (GMP-33) is an N-terminal proteolytic fragment of thrombospondin. Thromb Haemost: 2001; 86 3 887 893
74. Metzelaar M. J., Heijnen H. F., Sixma J. J., Nieuwenhuis H. K. Identification of a 33-Kd protein associated with the alpha-granule membrane (GMP-33) that is expressed on the surface of activated platelets. Blood: 1992; 79 2 372 379
75. Hayward C. P., Furmaniak-Kazmierczak E., Cieutat A. M., et al. Factor V is complexed with multimerin in resting platelet lysates and colocalizes with multimerin in platelet alpha-granules. J Biol Chem: 1995; 270 33 19217 19224
76. Hayward C. P., Smith J. W., Horsewood P., Warkentin T. E., Kelton J. G. p-155, a multimeric platelet protein that is expressed on activated platelets. J Biol Chem: 1991; 266 11 7114 7120
77. Wall J. E., Buijs-Wilts M., Arnold J. T., et al. A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents. Br J Haematol: 1995; 89 2 380 385
78. Ramström A. S., Fagerberg I. H., Lindahl T. L. A flow cytometric assay for the study of dense granule storage and release in human platelets. Platelets: 1999; 10 2-3 153 158
79. Gordon N., Thom J., Cole C., Baker R. Rapid detection of hereditary and acquired platelet storage pool deficiency by flow cytometry. Br J Haematol: 1995; 89 1 117 123
80. Nieuwenhuis H. K., van Oosterhout J. J., Rozemuller E., van Iwaarden F., Sixma J. J. Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood: 1987; 70 3 838 845
81. Silverstein R. L., Febbraio M. Identification of lysosome-associated membrane protein-2 as an activation-dependent platelet surface glycoprotein. Blood: 1992; 80 6 1470 1475
82. Israels S. J., McMillan E. M., Robertson C., Singhory S., McNicol A. The lysosomal granule membrane protein, LAMP-2, is also present in platelet dense granule membranes. Thromb Haemost: 1996; 75 4 623 629
83. Nishibori M., Cham B., McNicol A., Shalev A., Jain N., Gerrard J. M. The protein CD63 is in platelet dense granules, is deficient in a patient with Hermansky-Pudlak syndrome, and appears identical to granulophysin. J Clin Invest: 1993; 91 4 1775 1782
84. Febbraio M., Silverstein R. L. Identification and characterization of LAMP-1 as an activation-dependent platelet surface glycoprotein. J Biol Chem: 1990; 265 30 18531 18537
85. Södergren A. L., Svensson Holm A. B., Ramström S., Lindström E. G., Grenegård M., Öllinger K. Thrombin-induced lysosomal exocytosis in human platelets is dependent on secondary activation by ADP and regulated by endothelial-derived substances. Platelets: 2016; 27 1 86 92
86. Dachary-Prigent J., Freyssinet J. M., Pasquet J. M., Carron J. C., Nurden A. T. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood: 1993; 81 10 2554 2565
87. Albanyan A. M., Murphy M. F., Rasmussen J. T., Heegaard C. W., Harrison P. Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V. Transfusion: 2009; 49 1 99 107
88. Dasgupta S. K., Guchhait P., Thiagarajan P. Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5. Transl Res: 2006; 148 1 19 25
89. Shi J., Heegaard C. W., Rasmussen J. T., Gilbert G. E. Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature. Biochim Biophys Acta: 2004; 1667 1 82 90
90. Furman M. I., Krueger L. A., Frelinger A. L. III., et al. GPIIb-IIIa antagonist-induced reduction in platelet surface factor V/Va binding and phosphatidylserine expression in whole blood. Thromb Haemost: 2000; 84 3 492 498
91. Sims P. J., Faioni E. M., Wiedmer T., Shattil S. J. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem: 1988; 263 34 18205 18212
92. Holme P. A., Brosstad F., Solum N. O. Platelet-derived microvesicles and activated platelets express factor Xa activity. Blood Coagul Fibrinolysis: 1995; 6 4 302 310
93. Gilbert G. E., Sims P. J., Wiedmer T., Furie B., Furie B. C., Shattil S. J. Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem: 1991; 266 26 17261 17268
94. Schwarz U. R., Geiger J., Walter U., Eigenthaler M. Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets-definition and detection of ticlopidine/clopidogrel effects. Thromb Haemost: 1999; 82 3 1145 1152
95. 2+-ATPase inhibitors. Biochemistry: 1995; 34 36 11625 11634
96. Assinger A., Volf I., Schmid D. A novel, rapid method to quantify intraplatelet calcium dynamics by ratiometric flow cytometry. PLoS ONE: 2015; 10 4 e0122527
97. Davies T. A., Drotts D., Weil G. J., Simons E. R. Flow cytometric measurements of cytoplasmic calcium changes in human platelets. Cytometry: 1988; 9 2 138 142
98. Probes for membrane potential. In: Johnson I., Spence M. eds. The Molecular Probes® Handbook: A Guide to Fluorescent Probes and Labeling Technologies. 11th ed. Life Technologies: 2010; 924 936. Available at: www.lifetechnologies.com/handbook
99. Gyulkhandanyan A. V., Mutlu A., Freedman J., Leytin V. Markers of platelet apoptosis: methodology and applications. J Thromb Thrombolysis: 2012; 33 4 397 411
100. Bernardi P., Scorrano L., Colonna R., Petronilli V., Di Lisa F. Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur J Biochem: 1999; 264 3 687 701
101. Fox S. C., Burgess-Wilson M., Heptinstall S., Mitchell J. R. Platelet aggregation in whole blood determined using the Ultra-Flo 100 Platelet Counter. Thromb Haemost: 1982; 48 3 327 329
102. Tynngård N., Wallstedt M., Södergren A. L., Faxälv L., Ramström S. Platelet adhesion changes during storage studied with a novel method using flow cytometry and protein-coated beads. Platelets: 2015; 26 2 177 185
103. Michelson A. D., Barnard M. R., Krueger L. A., Valeri C. R., Furman M. I. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation: 2001; 104 13 1533 1537
104. Izzi B., Pampuch A., Costanzo S., et al. Determinants of platelet conjugate formation with polymorphonuclear leukocytes or monocytes in whole blood. Thromb Haemost: 2007; 98 6 1276 1284
105. Rinder H. M., Bonan J. L., Rinder C. S., Ault K. A., Smith B. R. Dynamics of leukocyte-platelet adhesion in whole blood. Blood: 1991; 78 7 1730 1737
106. Klinkhardt U., Harder S. Flow cytometric measurement of platelet-leukocyte aggregates: a possible target to monitor platelet function? Semin Thromb Hemost: 2005; 31 4 400 403
107. Bihari P., Fent J., Hamar J., Furész J., Lakatos S. An easy-to-use practical method to measure coincidence in the flow cytometer-the case of platelet-granulocyte complex determination. J Biochem Biophys Methods: 2008; 70 6 1080 1085
108. Hagberg I. A., Lyberg T. Evaluation of circulating platelet-leukocyte conjugates: a sensitive flow cytometric assay well suited for clinical studies. Platelets: 2000; 11 3 151 160
109. Michelson A. D., Barnard M. R., Hechtman H. B., et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A: 1996; 93 21 11877 11882
110. Hagberg I. A., Lyberg T. Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies. Platelets: 2000; 11 3 137 150
111. Li N., Hu H., Hjemdahl P. Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry. Thromb Res: 2003; 111 3 165 170
112. Rinder C. S., Student L. A., Bonan J. L., Rinder H. M., Smith B. R. Aspirin does not inhibit adenosine diphosphate-induced platelet alpha-granule release. Blood: 1993; 82 2 505 512
113. Chronos N. A., Wilson D. J., Janes S. L., Hutton R. A., Buller N. P., Goodall A. H. Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of alpha-granules or lysosomes from, human platelets. Clin Sci (Lond): 1994; 87 5 575 580
114. Scharbert G., Kalb M., Marschalek C., Kozek-Langenecker S. A. The effects of test temperature and storage temperature on platelet aggregation: a whole blood in vitro study. Anesth Analg: 2006; 102 4 1280 1284
115. Ramstrom S., O'Neill S., Dunne E., Kenny D. Annexin V binding to platelets is agonist, time and temperature dependent. Platelets: 2010; 21 4 289 296
116. Hui K. Y., Jakubowski J. A., Wyss V. L., Angleton E. L. Minimal sequence requirement of thrombin receptor agonist peptide. Biochem Biophys Res Commun: 1992; 184 2 790 796
117. Blackhart B. D., Emilsson K., Nguyen D., et al. Ligand cross-reactivity within the protease-activated receptor family. J Biol Chem: 1996; 271 28 16466 16471
118. Martorell L., Martínez-González J., Rodríguez C., Gentile M., Calvayrac O., Badimon L. Thrombin and protease-activated receptors (PARs) in atherothrombosis. Thromb Haemost: 2008; 99 2 305 315
119. Hollenberg M. D., Saifeddine M., Sandhu S., Houle S., Vergnolle N. Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo. Br J Pharmacol: 2004; 143 4 443 454
120. Morton L. F., Hargreaves P. G., Farndale R. W., Young R. D., Barnes M. J. Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity. Biochem J: 1995; 306 Pt 2 337 344
121. Kehrel B., Wierwille S., Clemetson K. J., et al. Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood: 1998; 91 2 491 499
122. Polgár J., Clemetson J. M., Kehrel B. E., et al. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J Biol Chem: 1997; 272 21 13576 13583
123. Shattil S. J., Budzynski A., Scrutton M. C. Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding, and aggregation in whole blood in the absence of other excitatory agonists. Blood: 1989; 73 1 150 158
124. Bundy G. L. The synthesis of prostaglandin endoperoxide analogs. Tetrahedron Lett: 1975; 24 1957 1960
125. Morinelli T. A., Niewiarowski S., Daniel J. L., Smith J. B. Receptor-mediated effects of a PGH2 analogue (U 46619) on human platelets. Am J Physiol: 1987; 253 5, Pt 2 H1035 H1043
126. Bergmeier W., Bouvard D., Eble J. A., et al. Rhodocytin (aggretin) activates platelets lacking alpha(2)beta(1) integrin, glycoprotein VI, and the ligand-binding domain of glycoprotein Ibalpha. J Biol Chem: 2001; 276 27 25121 25126
127. Manne B. K., Getz T. M., Hughes C. E., et al. Fucoidan is a novel platelet agonist for the C-type lectin-like receptor 2 (CLEC-2). J Biol Chem: 2013; 288 11 7717 7726
128. Suzuki-Inoue K., Inoue O., Ozaki Y. The novel platelet activation receptor CLEC-2. Platelets: 2011; 22 5 380 384
129. Li N., Wallén N. H., Ladjevardi M., Hjemdahl P. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis: 1997; 8 8 517 523
130. Hübl W., Assadian A., Lax J., et al. Assessing aspirin-induced attenuation of platelet reactivity by flow cytometry. Thromb Res: 2007; 121 1 135 143
131. Rukoyatkina N., Mindukshev I., Walter U., Gambaryan S. Dual role of the p38 MAPK/cPLA2 pathway in the regulation of platelet apoptosis induced by ABT-737 and strong platelet agonists. Cell Death Dis: 2013; 4 e931
132. Cohen H. J., Chovaniec M. E., Takahashi K., Whitin J. C. Activation of human granulocytes by arachidonic acid: its use and limitations for investigating granulocyte functions. Blood: 1986; 67 4 1103 1109
133. Ts'ao C., Holly C. M. Arachidonic acid causes lysis of human platelets in an artificial medium: protection by plasma. Prostaglandins: 1979; 17 5 775 784
134. Maclouf J., Levy-Toledano S., Savariau E., Hardisty R., Caen J. P. Arachidonic acid-induced human platelet aggregation independent of cyclooxygenase and lipoxygenase. Prostaglandins: 1984; 28 3 383 398
135. Lindahl T. L., Fagerberg I. H., Larsson A. A new flow cytometric method for measurement of von Willebrand factor activity. Scand J Clin Lab Invest: 2003; 63 3 217 223
136. Li S., Wang Z., Liao Y., et al. The glycoprotein Ibalpha-von Willebrand factor interaction induces platelet apoptosis. J Thromb Haemost: 2010; 8 2 341 350
137. Storey R. F., Sanderson H. M., White A. E., May J. A., Cameron K. E., Heptinstall S. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. Br J Haematol: 2000; 110 4 925 934
138. Blais N., Pharand C., Lordkipanidzé M., Sia Y. K., Merhi Y., Diodati J. G. Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). Thromb Haemost: 2009; 102 2 404 411
139. Dawood B. B., Wilde J., Watson S. P. Reference curves for aggregation and ATP secretion to aid diagnose of platelet-based bleeding disorders: effect of inhibition of ADP and thromboxane A(2) pathways. Platelets: 2007; 18 5 329 345
140. Dawood B. B., Lowe G. C., Lordkipanidzé M., et al. Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel. Blood: 2012; 120 25 5041 5049
141. Watson S. P., Lowe G. C., Lordkipanidzé M., Morgan N. V.; GAPP consortium. Genotyping and phenotyping of platelet function disorders. J Thromb Haemost: 2013; 11 01 351 363
142. Yee D. L., Sun C. W., Bergeron A. L., Dong J. F., Bray P. F. Aggregometry detects platelet hyperreactivity in healthy individuals. Blood: 2005; 106 8 2723 2729
143. Ruf A., Patscheke H. Flow cytometric detection of activated platelets: comparison of determining shape change, fibrinogen binding, and P-selectin expression. Semin Thromb Hemost: 1995; 21 2 146 151
144. Goodall A. H., Appleby J. Flow-cytometric analysis of platelet-membrane glycoprotein expression and platelet activation. In: Gibbins J. M., Mahaut-Smith M. P. eds. Methods in Molecular Biology. Vol. 272. Totowa, NJ Humana Press Inc.: 2004; 225 236
145. Schwartz A., Gaigalas A. K., Wang L., Marti G. E., Vogt R. F., Fernandez-Repollet E. Formalization of the MESF unit of fluorescence intensity. Cytometry B Clin Cytom: 2004; 57 1 1 6
146. CLSI Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory: Approved Guideline EP28-A3c. Wayne, PA Clinical and Laboratory Standards Institute: 2008
147. Linnet K. Nonparametric estimation of reference intervals by simple and bootstrap-based procedures. Clin Chem: 2000; 46 6, Pt 1 867 869
148. Horn P. S., Pesce A. J. Chemistry AAfC. Reference Intervals: A User's Guide. Washington, DC AACC Press: 2005
149. Siest G., Henny J., Gräsbeck R., et al. The theory of reference values: an unfinished symphony. Clin Chem Lab Med: 2013; 51 1 47 64
150. Gresele P., Harrison P., Bury L., et al. Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. J Thromb Haemost: 2014; 12 9 1562 1569
151. Hagberg I. A., Akkok C. A., Lyberg T., Kjeldsen-Kragh J. Apheresis-induced platelet activation:comparison of three types of cell separators. Transfusion: 2000; 40 2 182 192
152. Johnson L., Loh Y. S., Kwok M., Marks D. C. In vitro assessment of buffy-coat derived platelet components suspended in SSP+ treated with the INTERCEPT Blood system. Transfus Med: 2013; 23 2 121 129
153. Metcalfe P., Williamson L. M., Reutelingsperger C. P., Swann I., Ouwehand W. H., Goodall A. H. Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods. Br J Haematol: 1997; 98 1 86 95
154. Zhang J. G., Carter C. J., Culibrk B., et al. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma. Transfusion: 2008; 48 5 847 856
155. Krailadsiri P., Seghatchian J. Are all leucodepleted platelet concentrates equivalent? Comparison of Cobe LRS Turbo, Haemonetics MCS+ LD, and filtered pooled buffy-coat-derived platelets. Vox Sang: 2000; 78 3 171 175
156. Sandgren P., Saeed K. Storage of buffy-coat-derived platelets in additive solution: in vitro effects on platelets of the air bubbles and foam included in the final unit. Blood Transfus: 2011; 9 2 182 188
157. Apelseth T. O., Bruserud O, Wentzel-Larsen T., Bakken A. M., Bjorsvik S., Hervig T. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage. Transfusion: 2007; 47 4 653 665
158. Lozano M. L., Rivera J., Gónzález-Conejero R., Moraleda J. M., Vicente V. Loss of high-affinity thrombin receptors during platelet concentrate storage impairs the reactivity of platelets to thrombin. Transfusion: 1997; 37 4 368 375
159. Picker S. M., Schneider V., Gathof B. S. Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies. Transfusion: 2009; 49 6 1224 1232
160. Wang C., Mody M., Herst R., Sher G., Freedman J. Flow cytometric analysis of platelet function in stored platelet concentrates. Transfus Sci: 1999; 20 2 129 139
161. Sandgren P., Meinke S., Eckert E., Douagi I., Wikman A., Höglund P. Random aggregates in newly produced platelet units are associated with platelet activation and release of the immunomodulatory factors sCD40L and RANTES. Transfusion: 2014; 54 3 602 612
162. Holme S., Sweeney J. D., Sawyer S., Elfath M. D. The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability. Transfusion: 1997; 37 1 12 17
163. Rinder H. M., Murphy M., Mitchell J. G., Stocks J., Ault K. A., Hillman R. S. Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion: 1991; 31 5 409 414
164. Rinder H. M., Smith B. R. In vitro evaluation of stored platelets: is there hope for predicting posttransfusion platelet survival and function? Transfusion: 2003; 43 1 2 6
165. Mallouk N., Labruyère C., Reny J. L., et al. Prevalence of poor biological response to clopidogrel: a systematic review. Thromb Haemost: 2012; 107 3 494 506
166. Gorog D. A., Fuster V. Platelet function tests in clinical cardiology: unfulfilled expectations. J Am Coll Cardiol: 2013; 61 21 2115 2129
167. Jakubowski J. A., Bourguet N., Boulay-Moine D., et al. Comparison of a new ELISA assay with the flow cytometric assay for platelet vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation in whole blood to assess P2Y(12) inhibition. Thromb Haemost: 2012; 107 2 388 395
168. Gremmel T., Koppensteiner R., Panzer S. Comparison of aggregometry with flow cytometry for the assessment of agonistś-induced platelet reactivity in patients on dual antiplatelet therapy. PLoS ONE: 2015; 10 6 e0129666
169. Kirkpatrick A. C., Stoner J. A., Dale G. L., Prodan C. I. Elevated coated-platelets in symptomatic large-artery stenosis patients are associated with early stroke recurrence. Platelets: 2014; 25 2 93 96
170. Kirkpatrick A. C., Tafur A. J., Vincent A. S., Dale G. L., Prodan C. I. Coated-platelets improve prediction of stroke and transient ischemic attack in asymptomatic internal carotid artery stenosis. Stroke: 2014; 45 10 2995 3001
171. Prodan C. I., Dale G. L. Coated-platelets in ischemic stroke - potential insight into the etiology of stroke subtypes. Int J Stroke: 2008; 3 4 249 250
172. Prodan C. I., Vincent A. S., Dale G. L. Coated-platelet levels are elevated in patients with transient ischemic attack. Transl Res: 2011; 158 1 71 75
173. Prodan C. I., Stoner J. A., Cowan L. D., Dale G. L. Lower coated-platelet levels are associated with early hemorrhagic transformation in patients with non-lacunar brain infarction. J Thromb Haemost: 2010; 8 6 1185 1190
174. Prodan C. I., Vincent A. S., Dale G. L. Coated platelet levels correlate with bleed volume in patients with spontaneous intracerebral hemorrhage. Stroke: 2010; 41 6 1301 1303
175. Prodan C. I., Vincent A. S., Padmanabhan R., Dale G. L. Coated-platelet levels are low in patients with spontaneous intracerebral hemorrhage. Stroke: 2009; 40 7 2578 2580
176. Frelinger A. L. III, Grace R. F., Gerrits A. J., et al. Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP. Blood: 2015; 126 7 873 879
177. Linden M. D., Frelinger A. L. III, Barnard M. R., Przyklenk K., Furman M. I., Michelson A. D. Application of flow cytometry to platelet disorders. Semin Thromb Hemost: 2004; 30 5 501 511
178. Dovlatova N., Lordkipanidzé M., Lowe G. C., et al. UK GAPP Study Group. Evaluation of a whole blood remote platelet function test for the diagnosis of mild bleeding disorders. J Thromb Haemost: 2014; 12 5 660 665
179. Dovlatova N., May J. A., Fox S. C. Remote platelet function testing-Significant progress towards widespread testing in clinical practice. Platelets: 2015; 26 5 399 401
180. Connolly-Andersen A. M., Sundberg E., Ahlm C., et al. Increased thrombopoiesis and platelet activation in hantavirus-infected patients. J Infect Dis: 2015; 212 7 1061 1069